dnature has been in the media recently – the attached links are to articles in the New Zealand media on how we were able to assist in getting New Zealand laboratories underway with Covid-19 testing.
The Health Research Council, announced on Friday 17 April, that dnature diagnostics & research ltd were the recipients of funding for the purpose of developing a rapid, on-site DNA diagnostic test to detect the difference between influenza and COVID-19.
On Monday, John was interviewed by Radio New Zealand on the testing in New Zealand for Covid-19 as well as the work that dnature is doing to support this.
As many of you know, here in our lab at dnature, we absolutely love our Integra Viaflo Electronic Pipettes and we know that our customers do too. Some of the feedback that we’ve received includes:
DNA testing allows fast, sensitive and specific detection of particular target organisms & biological products. Similar methods are used commonly in hospitals (for disease organisms), forensics (for DNA profiles of offenders) and university laboratories.
Designing primers for your high resolution melting is easy enough. A quick run with some known genotypes …. and look for the melting curve differences among samples. Too simple. But what about the temperature-neutral SNP’s? The what?
American Foulbrood is a notifiable, bacterial disease that, if found, is required to be reported to the AFB management agency as well as the hive being destroyed.
dnature, is New Zealand’s lead DNA diagnostic laboratory in the development of DNA